A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA)

Clinical trial NCT06050954 · WITHDRAWN

Trial details

NCT number: NCT06050954
Sponsor: Fox Chase Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Urothelial Carcinoma

Start date: 2023-09-01
Primary completion: 2027-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.